Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginseng for Cancer Related Fatigue
NCT06395441Phase 3Recruiting
- Sponsor
- Mayo Clinic
- Start
- Aug 2024
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 3, randomised trial in cancer-related fatigue (CRF) (2 arms), sponsored by Mayo Clinic. Primary endpoint: Change in fatigue at 8 weeks. Started Aug 2024; status: recruiting.
02
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT06395441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06395441.